Maxcyte (MXCT) Return on Capital Employed (2021 - 2026)
Maxcyte (MXCT) reported Return on Capital Employed of 1.73% for Q1 2026, up 214.0% year-over-year from 0.55% in Q1 2025, and up 64.19% quarter-over-quarter from 4.84% in Q4 2025.
Maxcyte (MXCT) Return on Capital Employed (2021 - 2026) Analysis & Trends
Maxcyte (MXCT) has 6 years of Return on Capital Employed data on file, last reported at 1.73% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 1.73%, up 214.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.73% (up 214.0% YoY), and the FY2025 annual result was 4.53%, down 93.0% from the prior year.
- Return on Capital Employed advanced to 1.73% in Q1 2026 per MXCT's latest filing, from 4.84% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1.73% in Q1 2026 and troughed at 19.96% in Q3 2024.
- A 5-year average of 10.75% and a median of 9.42% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed tumbled 925 bps in 2023, then surged 1559 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 10.09% in 2022, then tumbled by 92 bps to 19.35% in 2023, then surged by 81 bps to 3.76% in 2024, then retreated by 29 bps to 4.84% in 2025, then surged by 64 bps to 1.73% in 2026.
- Business Quant data shows MXCT's Return on Capital Employed at 1.73% in Q1 2026, 4.84% in Q4 2025, and 5.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | -1.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73% |
| Dec 31, 2025 | -4.84% |
| Sep 30, 2025 | -5.47% |
| Jun 30, 2025 | -5.09% |
| Mar 31, 2025 | -3.88% |
| Dec 31, 2024 | -3.76% |
| Sep 30, 2024 | -19.96% |
| Jun 30, 2024 | -19.09% |
| Mar 31, 2024 | -18.99% |
| Dec 31, 2023 | -19.35% |
| Sep 30, 2023 | -18.61% |
| Jun 30, 2023 | -15.47% |
| Mar 31, 2023 | -13.60% |
| Dec 31, 2022 | -10.09% |
| Sep 30, 2022 | -9.42% |
| Jun 30, 2022 | -7.45% |
| Mar 31, 2022 | -5.87% |
| Dec 31, 2021 | -6.86% |
| Sep 30, 2021 | -4.07% |